New Immunotherapy Advances Presented at the AACR Annual Meeting 2015
Immunotherapeutics called PD-1 inhibitors have garnered a lot of attention in the past year thanks to exciting clinical trial...
Category: AACR
Immunotherapeutics called PD-1 inhibitors have garnered a lot of attention in the past year thanks to exciting clinical trial...
Hear from AACR President Carlos L. Arteaga, MD, and Annual Meeting Program Committee Chairperson Lewis C. Cantley, PhD, about...
With the start of the AACR Annual Meeting 2015 only four days away, the organization is ramping up its...
In addition to providing a forum for attendees to learn, network, and share information and ideas, the Annual Meeting...
Guest Post by Raymond DuBois, MD, PhD Arizona State University Biodesign Institute
In our first post of this Behind the Scenes series, you read about the years of planning that go...
The AACR is a proud production supporter of the new documentary CANCER: THE EMPEROR OF ALL MALADIES, airing on...
As Kidney Cancer Awareness Month draws to a close, Scott M. Welford, PhD, the 2014 recipient of the Kure...
When the AACR Annual Meeting 2015 begins April 18 in Philadelphia, more than 18,500 attendees will flow seamlessly through...
Guest Post by Matthew J. Sikora, PhD University of Pittsburgh Cancer Institute